(ENVX) Enovix - Ratings and Ratios
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US2935941078
Lithium-Ion Battery Cells, Wearables, Smartphone, Computing, Electric Vehicles
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 90.1% |
| Value at Risk 5%th | 135% |
| Relative Tail Risk | -8.56% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.29 |
| Alpha | -71.99 |
| CAGR/Max DD | -0.03 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.619 |
| Beta | 2.410 |
| Beta Downside | 2.145 |
| Drawdowns 3y | |
|---|---|
| Max DD | 75.42% |
| Mean DD | 44.68% |
| Median DD | 51.06% |
Description: ENVX Enovix November 09, 2025
Enovix Corp. (NASDAQ: ENVX) designs, develops, and manufactures advanced lithium-ion battery cells both in the United States and abroad, targeting markets that include wearables, IoT devices, smartphones, computing equipment, electric vehicles (EVs), and original equipment manufacturers (OEMs). The firm was founded in 2007 and is headquartered in Fremont, California.
Key recent metrics (as disclosed in the company’s Q2 2024 filing) show revenue of roughly $13 million, up about 45 % year-over-year, and a production capacity ramp-up plan to reach 30 GWh annually by 2026. Enovix’s 3-D silicon-anode architecture claims energy densities of 450 Wh/kg, positioning it to benefit from the EV sector’s shift toward higher-range batteries and the U.S. Inflation Reduction Act’s incentives for domestically produced battery cells.
For a deeper, data-driven assessment of ENVX’s valuation and risk profile, you may find the analytical tools on ValueRay useful for extending your research.
Piotroski VR‑10 (Strict, 0-10) 0.5
| Net Income (-159.2m TTM) > 0 and > 6% of Revenue (6% = 1.82m TTM) |
| FCFTA -0.13 (>2.0%) and ΔFCFTA 33.65pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 1744 % (prev 793.4%; Δ 951.0pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.09 (>3.0%) and CFO -84.2m > Net Income -159.2m (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 9.72 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (206.8m) change vs 12m ago 16.93% (target <= -2.0% for YES) |
| Gross Margin 15.38% (prev -74.67%; Δ 90.05pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 4.45% (prev 4.63%; Δ -0.18pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -8.42 (EBITDA TTM -108.2m / Interest Expense TTM 16.9m) >= 6 (WARN >= 3) |
Altman Z'' -2.58
| (A) 0.58 = (Total Current Assets 588.6m - Total Current Liabilities 60.6m) / Total Assets 913.7m |
| (B) -1.03 = Retained Earnings (Balance) -942.8m / Total Assets 913.7m |
| warn (B) unusual magnitude: -1.03 — check mapping/units |
| (C) -0.21 = EBIT TTM -142.4m / Avg Total Assets 680.9m |
| (D) -1.53 = Book Value of Equity -943.5m / Total Liabilities 616.6m |
| Total Rating: -2.58 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 33.12
| 1. Piotroski 0.50pt |
| 2. FCF Yield -9.98% |
| 3. FCF Margin data missing |
| 4. Debt/Equity 0.07 |
| 5. Debt/Ebitda 2.90 |
| 6. ROIC - WACC (= -42.32)% |
| 7. RoE -64.99% |
| 8. Rev. Trend 75.10% |
| 9. EPS Trend 22.12% |
What is the price of ENVX shares?
As of January 09, 2026, the stock is trading at USD 7.91 with a total of 5,369,163 shares traded.
Over the past week, the price has changed by +0.25%, over one month by -8.87%, over three months by -37.52% and over the past year by -35.32%.
Over the past week, the price has changed by +0.25%, over one month by -8.87%, over three months by -37.52% and over the past year by -35.32%.
Is ENVX a buy, sell or hold?
Enovix has received a consensus analysts rating of 4.54.
Therefore, it is recommended to buy ENVX.
- Strong Buy: 9
- Buy: 2
- Hold: 2
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the ENVX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 26.9 | 240.1% |
| Analysts Target Price | 26.9 | 240.1% |
| ValueRay Target Price | 7.8 | -1.4% |
ENVX Fundamental Data Overview January 04, 2026
P/S = 56.729
P/B = 5.3614
Beta = 2.116
Revenue TTM = 30.3m USD
EBIT TTM = -142.4m USD
EBITDA TTM = -108.2m USD
Long Term Debt = 518.3m USD (from longTermDebt, last quarter)
Short Term Debt = 10.2m USD (from shortTermDebt, last quarter)
Debt = 21.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -313.9m USD (from netDebt column, last quarter)
Enterprise Value = 1.18b USD (1.72b + Debt 21.6m - CCE 558.8m)
Interest Coverage Ratio = -8.42 (Ebit TTM -142.4m / Interest Expense TTM 16.9m)
FCF Yield = -9.98% (FCF TTM -117.8m / Enterprise Value 1.18b)
FCF Margin = -389.2% (FCF TTM -117.8m / Revenue TTM 30.3m)
Net Margin = -525.9% (Net Income TTM -159.2m / Revenue TTM 30.3m)
Gross Margin = 15.38% ((Revenue TTM 30.3m - Cost of Revenue TTM 25.6m) / Revenue TTM)
Gross Margin QoQ = 17.53% (prev 26.00%)
Tobins Q-Ratio = 1.29 (Enterprise Value 1.18b / Total Assets 913.7m)
Interest Expense / Debt = 54.56% (Interest Expense 11.8m / Debt 21.6m)
Taxrate = 0.78% (-422.0k / -54.2m)
NOPAT = -141.3m (EBIT -142.4m * (1 - 0.78%)) [loss with tax shield]
Current Ratio = 9.72 (Total Current Assets 588.6m / Total Current Liabilities 60.6m)
Debt / Equity = 0.07 (Debt 21.6m / totalStockholderEquity, last quarter 294.3m)
Debt / EBITDA = 2.90 (negative EBITDA) (Net Debt -313.9m / EBITDA -108.2m)
Debt / FCF = 2.66 (negative FCF - burning cash) (Net Debt -313.9m / FCF TTM -117.8m)
Total Stockholder Equity = 245.0m (last 4 quarters mean from totalStockholderEquity)
RoA = -23.38% (Net Income -159.2m / Total Assets 913.7m)
RoE = -64.99% (Net Income TTM -159.2m / Total Stockholder Equity 245.0m)
RoCE = -18.66% (EBIT -142.4m / Capital Employed (Equity 245.0m + L.T.Debt 518.3m))
RoIC = -27.61% (negative operating profit) (NOPAT -141.3m / Invested Capital 511.8m)
WACC = 14.72% (E(1.72b)/V(1.74b) * Re(14.90%) + (debt cost/tax rate unavailable))
Discount Rate = 14.90% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 6.60%
Fair Price DCF = unknown (Cash Flow -117.8m)
EPS Correlation: 22.12 | EPS CAGR: 14.53% | SUE: 2.82 | # QB: 1
Revenue Correlation: 75.10 | Revenue CAGR: 1833 % | SUE: 0.04 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.15 | Chg30d=+0.001 | Revisions Net=-2 | Analysts=7
EPS next Year (2026-12-31): EPS=-0.60 | Chg30d=-0.030 | Revisions Net=-4 | Growth EPS=-0.5% | Growth Revenue=+134.7%
P/B = 5.3614
Beta = 2.116
Revenue TTM = 30.3m USD
EBIT TTM = -142.4m USD
EBITDA TTM = -108.2m USD
Long Term Debt = 518.3m USD (from longTermDebt, last quarter)
Short Term Debt = 10.2m USD (from shortTermDebt, last quarter)
Debt = 21.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -313.9m USD (from netDebt column, last quarter)
Enterprise Value = 1.18b USD (1.72b + Debt 21.6m - CCE 558.8m)
Interest Coverage Ratio = -8.42 (Ebit TTM -142.4m / Interest Expense TTM 16.9m)
FCF Yield = -9.98% (FCF TTM -117.8m / Enterprise Value 1.18b)
FCF Margin = -389.2% (FCF TTM -117.8m / Revenue TTM 30.3m)
Net Margin = -525.9% (Net Income TTM -159.2m / Revenue TTM 30.3m)
Gross Margin = 15.38% ((Revenue TTM 30.3m - Cost of Revenue TTM 25.6m) / Revenue TTM)
Gross Margin QoQ = 17.53% (prev 26.00%)
Tobins Q-Ratio = 1.29 (Enterprise Value 1.18b / Total Assets 913.7m)
Interest Expense / Debt = 54.56% (Interest Expense 11.8m / Debt 21.6m)
Taxrate = 0.78% (-422.0k / -54.2m)
NOPAT = -141.3m (EBIT -142.4m * (1 - 0.78%)) [loss with tax shield]
Current Ratio = 9.72 (Total Current Assets 588.6m / Total Current Liabilities 60.6m)
Debt / Equity = 0.07 (Debt 21.6m / totalStockholderEquity, last quarter 294.3m)
Debt / EBITDA = 2.90 (negative EBITDA) (Net Debt -313.9m / EBITDA -108.2m)
Debt / FCF = 2.66 (negative FCF - burning cash) (Net Debt -313.9m / FCF TTM -117.8m)
Total Stockholder Equity = 245.0m (last 4 quarters mean from totalStockholderEquity)
RoA = -23.38% (Net Income -159.2m / Total Assets 913.7m)
RoE = -64.99% (Net Income TTM -159.2m / Total Stockholder Equity 245.0m)
RoCE = -18.66% (EBIT -142.4m / Capital Employed (Equity 245.0m + L.T.Debt 518.3m))
RoIC = -27.61% (negative operating profit) (NOPAT -141.3m / Invested Capital 511.8m)
WACC = 14.72% (E(1.72b)/V(1.74b) * Re(14.90%) + (debt cost/tax rate unavailable))
Discount Rate = 14.90% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 6.60%
Fair Price DCF = unknown (Cash Flow -117.8m)
EPS Correlation: 22.12 | EPS CAGR: 14.53% | SUE: 2.82 | # QB: 1
Revenue Correlation: 75.10 | Revenue CAGR: 1833 % | SUE: 0.04 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.15 | Chg30d=+0.001 | Revisions Net=-2 | Analysts=7
EPS next Year (2026-12-31): EPS=-0.60 | Chg30d=-0.030 | Revisions Net=-4 | Growth EPS=-0.5% | Growth Revenue=+134.7%
Additional Sources for ENVX Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle